CHRS
Coherus BioSciences Inc.
Company Overview
| Mkt Cap | $187.13M | Price | $1.68 |
| Volume | 774.16K | Change | -1.18% |
| P/E Ratio | 6.6 | Open | $1.68 |
| Revenue | $267.0M | Prev Close | $1.70 |
| Net Income | $28.5M | 52W Range | $0.66 - $2.43 |
| Div Yield | N/A | Target | $4.51 |
| Overall | 57 | Value | 60 |
| Quality | 50 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyCoherus BioSciences Inc. (CHRS) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.68 with a market capitalization of $187.13 million. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows CHRS with a volume of 774K shares. The stock opened down 1.18% from yesterday's close of $1.70. Current analyst estimates project earnings of $-1.62 per share for this year, with next year targeting $-0.65.
CHRS demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including ACOR, ARNA, AMGN, RGEN.
Key investment considerations for CHRS include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 168.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:14 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHRS | $1.68 | -1.2% | 774.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Coherus BioSciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW